Recent Updates
Recently added Catalysts
ETON Positive Sentiment Score: 60/100

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Tuesday, July 30, 2024 2 min read
Key Takeaway: Eton Pharmaceuticals announced it will report its second quarter 2024 financial results on August 8, 2024. Management will host a conference call and live audio webcast at 4:30 p.m. ET to discuss these results and answer questions from investors. The company specializes in developing treatments for rare diseases and has five commercial products along with three candidates in late-stage development. This proactive reporting indicates ongoing business activity and engagement with investors.

Market Sentiment Analysis

POSITIVE FACTORS

  • Eton is reporting second quarter financial results, showing proactive financial management.
  • The company continues to focus on rare disease treatments with multiple products and candidates.
  • Management engagement through a conference call allows for investor interaction.

Full Press Release Details

DEER PARK, Ill., July 30, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report second quarter 2024 financial results on Thursday, August 8, 2024. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT).
Dial in* (Audio Only) Click Here
Webcast: Click Here
In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com.
The live webcast can also be accessed on the Investors section of Eton’s website at https://ir.etonpharma.com/. An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.
*Conference call participants should register to obtain their dial-in and passcode details. Please be sure to register using a valid email address.
About Eton Pharmaceuticals
Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has five commercial rare disease products: ALKINDI SPRINKLE®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.
In-Site Communications, Inc.
E: lwilson@insitecony.com
Source: Eton Pharmaceuticals

Frequently Asked Questions

When will Eton Pharmaceuticals report its Q2 2024 financial results?

Eton Pharmaceuticals will report its Q2 2024 financial results on August 8, 2024.

What time is the Eton conference call for financial results?

The conference call will be held at 4:30 p.m. ET on August 8, 2024.

How can investors submit questions during the conference call?

Investors can submit questions via email to investorrelations@etonpharma.com.

Where can I access the live webcast of the conference call?

The live webcast can be accessed on Eton's Investors section of their website.

What rare disease products does Eton currently offer?

Eton offers five rare disease products, including ALKINDI SPRINKLE® and Nitisinone.

Tags: ETON Viatris Investor Conferences Healthcare Eton Pharmaceuticals Q2 2024 results rare diseases financial results Eton
Last updated: Jul 30, 2024